Gray, J. E. and Owonikoko, T. K. and Kato, T. and Nadal, E. and Greystoke, A. and Cardona, A. F. and Penrod, J. and Wei, Z. and Lara-Guerra, H. and Schulz, C. (2020) Randomized, placebo-controlled phase III study of 1L pembrolizumab (Pembro) plus carboplatin/taxane followed by pembro with or without maintenance olaparib in patients (Pts) with metastatic squamous non-small cell lung cancer (sqNSCLC): KEYLYNK-008. In: ESMO Virtual Congress, SEP 19-OCT 18, 2020, ELECTR NETWORK.
Full text not available from this repository.
Official URL: https://www.sciencedirect.com/journal/annals-of-on...
| Item Type: | Conference or Workshop Item (UNSPECIFIED) |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin II |
| Depositing User: | Petra Gürster |
| Date Deposited: | 16 Apr 2021 05:15 |
| Last Modified: | 16 Apr 2021 05:15 |
| URI: | https://pred.uni-regensburg.de/id/eprint/43891 |
Actions (login required)
 |
View Item |
